It's an interesting bio.
The nearest competitor, NA1 (NoNo) is currently on Phase 3 trial (expected to completed December 2020).
But AGN's is still pre-clinical.
It takes NoNo 8 years from Phase 1 to Phase 3.
I think it's a long way to go.
ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-2
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
0.005(0.89%) |
Mkt cap ! $69.39M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 56.5¢ | 54.5¢ | $66.76K | 119.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 19788 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 23856 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
55.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 56.0¢ | 56.5¢ | 55.0¢ | 26651 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| AGN (ASX) Chart |